Sign in
4

Changes in Ownership

TriSalus Life Sciences, Inc. Filed Acc 0001628280-26-047217

Chief Financial Officer gave up 14,650 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patience David Chief Financial Officer 2026-07-01 Shares withheld for taxes −14,650 $4.46 $65,339 261,107 D
Loading xslF345X06/wk-form4_1783368070.xml…